GSK Consumer Healthcare (GCHL) reported lower-than-expected Q1FY17 net sales with YoY decline of 1.6% to | 1002.6 crore (I-direct estimate: | 1040.2 crore). Adjusting for the impact of Ind AS, net sales were at | 934 crore. Other operating income increased 3.8% YoY to | 56.8 crore on the back of 13% increase in business auxiliary income..ICICI Securities Limited maintain BUY recommendation with a target price of | 6765 per share.Trendlyne has 9 reports on GSKCONS updated in the last year from 3 brokers with an average target of Rs 6485. Brokers have a rating for GSKCONS with 1 downgrade,3 price downgrades,1 upgrade and 2 price upgrades in past 6 months.